APGE
Apogee Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -10.5% ·
flujo de acciones -0.1% ·
nuevas posiciones netas -11.8%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +12 | 31.80M | $4.18B | +21 | −9 |
| Q1 2026 | 96 | +7 | 41.18M | $3.45B | +13 | −6 |
| Q4 2025 | 88 | 0 | 38.24M | $2.89B | — | — |
| Q3 2025 | 17 | -2 | 25.40M | $1.01B | — | −2 |
| Q2 2025 | 16 | +1 | 22.08M | $959.13M | +1 | — |
| Q1 2025 | 12 | -1 | 10.37M | $387.41M | — | −1 |
| Q4 2024 | 13 | +4 | 9.16M | $415.03M | +4 | — |
| Q3 2024 | 8 | -5 | 7.45M | $437.40M | — | −5 |
| Q2 2024 | 13 | — | 6.20M | $244.16M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 6.92M | +0.1% | $274.79M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 2 | Wellington Management ✦ | 4.72M | +24.1% | $187.67M | 0.0% | ▲ Add | 6 | SEC ↗ ×7 |
| 3 | BlackRock ✦ (pasivo) | 2.69M | +4.8% | $106.72M | 0.0% | ▲ Add | 2 | SEC ↗ ×11 |
| 4 | JPMorgan Chase ✦ | 2.28M | — | $90.40M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 5 | The Vanguard Group ✦ (pasivo) | 2.25M | +6.5% | $89.22M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 6 | State Street Global Advisors ✦ (pasivo) | 1.66M | +31.5% | $65.77M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.17M | +135.9% | $46.45M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Geode Capital Management ✦ (pasivo) | 892.20K | +14.0% | $35.45M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 750.53K | -1.4% | $29.82M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | Goldman Sachs Group ✦ | 599.62K | — | $23.82M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Morgan Stanley ✦ | 464.96K | — | $18.47M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 12 | Millennium Management ✦ | 430.46K | +75.6% | $17.10M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 235.00K | -81.8% | $9.34M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Capital World Investors ✦ | 127.62K | -34.2% | $5.07M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 122.38K | +5.8% | $4.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 100.57K | -48.3% | $4.00M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Marshall Wace ✦ | 7.03K | -92.2% | $279,183 | 0.0% | ▼ Trim | 6 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Point72 Asset Management | $53.44M | era 0.1% |
| Renaissance Technologies | $1.78M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 224 tenedores, 77.95M acciones, $5.58B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
9.8% de clase · Ver presentación original ante la SEC ↗